全文获取类型
收费全文 | 18311篇 |
免费 | 2126篇 |
国内免费 | 542篇 |
专业分类
耳鼻咽喉 | 13篇 |
儿科学 | 314篇 |
妇产科学 | 53篇 |
基础医学 | 1032篇 |
口腔科学 | 56篇 |
临床医学 | 2087篇 |
内科学 | 2715篇 |
皮肤病学 | 170篇 |
神经病学 | 449篇 |
特种医学 | 456篇 |
外科学 | 2138篇 |
综合类 | 3845篇 |
现状与发展 | 3篇 |
一般理论 | 1篇 |
预防医学 | 950篇 |
眼科学 | 2810篇 |
药学 | 1758篇 |
11篇 | |
中国医学 | 2054篇 |
肿瘤学 | 64篇 |
出版年
2024年 | 89篇 |
2023年 | 489篇 |
2022年 | 681篇 |
2021年 | 1029篇 |
2020年 | 942篇 |
2019年 | 751篇 |
2018年 | 784篇 |
2017年 | 884篇 |
2016年 | 900篇 |
2015年 | 887篇 |
2014年 | 1407篇 |
2013年 | 1395篇 |
2012年 | 1296篇 |
2011年 | 1406篇 |
2010年 | 1014篇 |
2009年 | 833篇 |
2008年 | 777篇 |
2007年 | 757篇 |
2006年 | 648篇 |
2005年 | 616篇 |
2004年 | 471篇 |
2003年 | 377篇 |
2002年 | 328篇 |
2001年 | 295篇 |
2000年 | 215篇 |
1999年 | 196篇 |
1998年 | 181篇 |
1997年 | 177篇 |
1996年 | 124篇 |
1995年 | 98篇 |
1994年 | 87篇 |
1993年 | 74篇 |
1992年 | 76篇 |
1991年 | 49篇 |
1990年 | 40篇 |
1989年 | 63篇 |
1988年 | 51篇 |
1987年 | 50篇 |
1986年 | 39篇 |
1985年 | 66篇 |
1984年 | 49篇 |
1983年 | 34篇 |
1982年 | 57篇 |
1981年 | 40篇 |
1980年 | 36篇 |
1979年 | 17篇 |
1978年 | 17篇 |
1977年 | 13篇 |
1976年 | 12篇 |
1973年 | 12篇 |
排序方式: 共有10000条查询结果,搜索用时 234 毫秒
101.
目的观察刺五加注射液及抗凝剂(潘生丁、肠溶阿斯匹林)对糖尿病足早期干预治疗的影响。方法将符合1999年WHO诊断标准的100例糖尿病合并早期足病变的患者分为两组:干预治疗组50例,对照组50例。在控制血糖、血压、糖尿病教育的基础上,干预组予以静滴刺五加注射液及口服抗凝剂(潘生丁、肠溶阿斯匹林)治疗,对照组为口服VitB1、VitB6、复方丹参片治疗。观察治疗前后两组患者足背动脉搏动、皮肤颜色、温度,痛、温、触觉等相关指征,血糖、HbA1c、血TG、TC、HDL-C,及血流变学、眼底病变、心脑血管事件发生率等。结果干预组糖尿病足病变治疗好转率高,恶化发展率低,心脑血管事件发生率少。血脂、血流变学、下肢血管多普勒彩超及眼底病变等好转改善明显,与对照组比较差异有统计学意义(P<0.05或P<0.01)。结论刺五加注射液及抗凝剂(潘生丁、肠溶阿斯匹林)对糖尿病足病变的早期干预治疗疗效显著,有重要的临床意义。 相似文献
102.
Abstract. This study examined the ability of nitrova-sodilator treatment with isosorbide dinitrate to prevent the development of reduced nerve conduction velocity and nutritive blood flow in streptozotocin-induced diabetes mellitus in rats. Two month untreated diabetes caused approximately 23% and 13% reductions in sciatic motor and saphenous nerve sensory conduction velocity ( P < 0.001). Isosorbide dinitrate treatment provided 64.6 and 67.6% protection for motor and sensory nerves, respectively ( P < 0.01). Sciatic endoneurial nutritive blood flow was measured by microelectrode polarography and a hydrogen clearance technique. After 1 month untreated diabetes, flow was reduced by 41.9% ( P < 0.001). Isosorbide dinitrate treatment for 1 month in non-diabetic and diabetic rats significantly increased blood flow ( P < 0.01). When between-group variations in blood pressure were taken into account, vascular conductance increased by 29% and 31% in non-diabetic and diabetic rats, respectively ( P < 0.01). Thus, nitrovasodilator treatment improves nerve perfusion and function in experimental diabetes, probably by compensating for reduced endothelium-derived nitric oxide release or action. 相似文献
103.
104.
成年人马蹄内翻足的分型与外科治疗 总被引:3,自引:2,他引:1
1984~1995年共收治各种马蹄内翻足1074例,18岁以上的成年人491例,术后获得1年以上随访者296例,男173例,女123例。年龄最小18岁,最大61岁,平均27.8岁。其中>45岁者9例。左下肢139例,右下肢120例,双下肢37例,共333个足。导致马蹄内翻足的病因14种,其中小儿麻痹后遗症175例,占59.1%。333个足共施行369人次手术,30例畸形严重者分两期手术矫正。6例因术后畸形矫正不足,关节融合不好又施行了二次手术。术后随访1年~8年9个月,平均3.5年,优321个足,占96.4%。差12个足。 相似文献
105.
目的 探讨高级糖化终产物与糖尿病并发症的关系。方法 采用本实验室自行研制的竞争性酶联免疫吸附分析方法,测定了糖尿病有并发症组病人血浆95例,糖尿病无并发症组人血浆65例,正常对照65例。结果:在糖尿病有并发症组中,高级糖化终产物(AGEs)浓度[(6.625(1.691)U/mL,n=95]明显高于糖尿病无并发症组[(5.904(2.071)U/mL,n=65,P=0.017],也明显高于正常人组[(5.337(1.138,n=65,p〈0.005]。以有无并发症为应变量进行多元logistic回归分析显示,血浆AGEs浓度〉6.085U/ml者,糖尿病并发症发生的危险性增加(OR值为2.989,95%可信限为1.407—6.350)。多元逐步线性回归显示:糖尿病病程、冠心病史与血浆AGEs浓度之间有线性关系。结论血浆AGEs浓度是糖尿病发生并发症的独立危险因素。 相似文献
106.
目的评估伊那普利治疗糖尿病肾病(DN)的临床疗效 ,并探讨其作用机制。方法40例持续微量蛋白尿的非胰岛素依赖型糖尿病(NIDDM)患者随机分为常规治疗组(n=19)和伊那普利治疗组(n=21)。利用 131I -邻碘马尿酸钠测定有效肾血浆流量(ERPF) ;肾小球滤过率(GFR)以内生肌酐清除率表示 ;通过ELISA法测定尿微量蛋白 ,包括白蛋白(ALB)、转铁蛋白(TF)、视黄醇结合蛋白(RBP)和N -乙酰 - β氨基葡萄糖苷酶(NAG)。结果伊那普利治疗组增高的尿ALB、TF、RBP和NAG均显著下降 ;ERPF显著增加 ;增加的滤过分数(FF)显著减低。而常规治疗组这些参数无显著变化。结论伊那普利具有改善DN患者的肾小球血流动力学 ,保护肾小球和肾小管功能的作用 相似文献
107.
K. Van Der Torren G. Groeneweg G. Van Lith 《Documenta ophthalmologica. Advances in ophthalmology》1988,69(2):153-159
Studying the oscillatory potentials in diabetic retinopathy, the authors experienced several problems interpreting results of digital filtering. The main problem was the separation of the first potential from the a-wave, since their frequencies are within the same range. To improve the procedure of measuring implicit times and of calculating amplitudes, the filtering was started with a finite impulse response filter and followed by a fast Fourier transform. The power of the oscillatory potential was calculated by determining the dominant frequency in the Fourier transformed response and expressed in microwatts. A group of normal subjects was compared with a group of early diabetic retinopathy patients. It appears that even in pathological circumstances a quantitative expression of the oscillatory potential is possible. 相似文献
108.
109.
Watanabe Y.; Yuzawa Y.; Mizumoto D.; Tamai H.; Itoh Y.; Kumon S.; Yamazaki C. 《Nephrology, dialysis, transplantation》1993,8(8):725-734
We studied the long-term outcome of 268 patients suffering fromdiabetic end-stage renal disease (DM-ESRD) treated with long-termhaemodialysis between 1978 and 1991, with special emphasis onvisual acuity as well as the heterogeneity of DM-ESRD The 50%patient survival on haemodialysis was 60 months. Visual disturbanceswere found in 73.1% (392/536) of eyes at the start of haemodialysis.Chronological assess ment of visual acuity demonstrated thestabilization of visual acuity and 87.1% (364/418) of eyes werestable, 4.8% (20/418) were improved, and 8.1% (34/418) wereaggravated in the long term respectively. The change of visualacuity was frequently seen in the short term, and rapid shiftsof body fluid to correct overhydration induced abrupt changesof glycaemic control as well as retraction of macular oedema.Hence it might be one of the factors affecting rapid changeof visual acuity in the short term. Meanwhile, long-term deterioration of visual acuity resulted from either hyperten sionunresponsive to medical treatment or poor glycaemic control.Some DM-ESRD patients had only background retinopathy at thestart of haemodialysis and these were likely to have the nephroscleroticglomerular lesion. They were old, not nephrotic and had a milddegree of diabetes during the predialysis stage. Thus, DM-ESRDpatients seem to have some heterogeneity in their clinical characteristics,and old DM-ESRD patients with only background retinopathy havethe appearance of diabetic macroangiopathy rather than microangiopathy. 相似文献
110.
Schmidt S.; Giessel R.; Bergis K. H.; Strojek K.; Grzeszczak W.; Ganten D.; Ritz E.; the Diabetic Nephropathy Study Group 《Nephrology, dialysis, transplantation》1996,11(9):1755-1761
BACKGROUND.: There is agreement that a family history of hypertension (HT),is a predictor for the risk of diabetic nephropathy (DN) inpatients with type 2 diabetes, and possibly also type 1 diabetes.It follows that genes related to the risk of hypertension mustalso be considered candidate genes for DN. The 235T allele ofthe angiotensinogen gene was found to be related to primaryHT. METHODS.: To examine whether it is predictive for DN as well, we examinedthe angiotensinogen gene polymorphism in 230 healthy local controls,423 patients with type 1 diabetes (n=180 with DN; n=243 withoutDN) and 663 patients with type 2 diabetes (n=310 with DN; n=353without DN). The angiotensinogen gene M235T polymorphism wasdetermined using PCR amplification. RESULTS.: The following results were obtained (i) no significant differenceof genotype distribution (type 1: MM/MT/TT(%) 27.6/57.2/15.2vs. 27.2/56.1/16.7 (P=0.92); type 2: MM/MT/TT (%) 31.7/48.2/20.1vs. 32.9/46.8/20.3 (P=0.93)) or allele frequencies (type 1:M 0.56 vs. 0.55 (P=0.795); type 2: M 0.56 vs. 0.56 (P=0.86))was found, between diabetic patients with or without DN, (ii)no difference was found between normotensive and hypertensivediabetic patients. CONCLUSION.: The data argue against a role of the angiotensinogen gene M235Tpolymorphism in the manifestation of diabetic nephropathy orhypertension in diabetic patients. 相似文献